Wawel SA
F:0K6
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
N/A
N/A
|
| Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one 0K6 stock under the Base Case scenario is 20.65 EUR. Compared to the current market price of 21.8 EUR, Wawel SA is Overvalued by 5%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Wawel SA.
| JP |
G
|
Goyo Foods Industry Co Ltd
TSE:2230
|
|
| CH |
|
Nestle SA
SIX:NESN
|
|
| US |
|
Mondelez International Inc
NASDAQ:MDLZ
|
|
| FR |
|
Danone SA
PAR:BN
|
|
| ZA |
T
|
Tiger Brands Ltd
JSE:TBS
|
|
| CN |
|
Muyuan Foods Co Ltd
SZSE:002714
|
|
| US |
|
Hershey Co
NYSE:HSY
|
|
| ZA |
A
|
Avi Ltd
JSE:AVI
|
|
| CH |
|
Chocoladefabriken Lindt & Spruengli AG
SIX:LISN
|
|
| CN |
|
Foshan Haitian Flavouring and Food Co Ltd
SSE:603288
|
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Revenue & Expenses Breakdown
Wawel SA
Balance Sheet Decomposition
Wawel SA
| Current Assets | 479.3m |
| Cash & Short-Term Investments | 253.6m |
| Receivables | 92.6m |
| Other Current Assets | 133.2m |
| Non-Current Assets | 378.6m |
| Long-Term Investments | 52.1m |
| PP&E | 312.5m |
| Intangibles | 5.5m |
| Other Non-Current Assets | 8.6m |
| Current Liabilities | 96.5m |
| Accounts Payable | 51.4m |
| Accrued Liabilities | 27.2m |
| Other Current Liabilities | 17.9m |
| Non-Current Liabilities | 20.4m |
| Long-Term Debt | 7.2m |
| Other Non-Current Liabilities | 13.1m |
Free Cash Flow Analysis
Wawel SA
| PLN | |
| Free Cash Flow | PLN |
Earnings Waterfall
Wawel SA
|
Revenue
|
734.6m
PLN
|
|
Cost of Revenue
|
-516m
PLN
|
|
Gross Profit
|
218.6m
PLN
|
|
Operating Expenses
|
-134.8m
PLN
|
|
Operating Income
|
83.7m
PLN
|
|
Other Expenses
|
-4.7m
PLN
|
|
Net Income
|
79m
PLN
|
0K6 Profitability Score
Profitability Due Diligence
Wawel SA's profitability score is 53/100. The higher the profitability score, the more profitable the company is.
Score
Wawel SA's profitability score is 53/100. The higher the profitability score, the more profitable the company is.
0K6 Solvency Score
Solvency Due Diligence
Wawel SA's solvency score is 99/100. The higher the solvency score, the more solvent the company is.
Score
Wawel SA's solvency score is 99/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
0K6 Price Targets Summary
Wawel SA
According to Wall Street analysts, the average 1-year price target for 0K6 is 19.95 EUR with a low forecast of 19.75 EUR and a high forecast of 20.54 EUR.
Dividends
Current shareholder yield for WWL is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one 0K6 stock under the Base Case scenario is 20.65 EUR.
Compared to the current market price of 21.8 EUR, Wawel SA is Overvalued by 5%.